Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses

Abstract excerpt

Objectiveand design: Considering the clinical link between non-alcoholic fatty liver disease (NAFLD) and atherosclerosis (AS), we performed bioinformatics analysis to uncover their pathogenic interrelationship.Methods and resultsData from the U.S. National Health and Nutritional Examination Survey (NHANES) 1999–2018 were included. Among 4851 participants in NHANES, NAFLD was significantly associated with...

Topics

Join the communities discussing this publication.

• Atherosclerosis and Cardiovascular Diseases
• Liver Disease Diagnosis and Treatment
• Single-cell and spatial transcriptomics